UPCOMING SESSIONS in ET
Tue, Jun 16, 2026
5:00 – 6:00 AM Bangkok
Advocacy 201: Using Your Experience to Improve Care for the Next Patient Thomas Bartlett Click Here To Register
UPCOMING SESSIONS in ET
Tue, Jun 16, 2026 · 5:00 – 6:00 AM Bangkok
Advocacy 201: Using Your Experience to Improve Care for the Next Patient
Thomas Bartlett
Click Here To Register
View all sessions
Apr 02, 2025
AbstractClinical ConditionCardiac Amyloidosis (CA).Key QuestionsWhen should infiltrative cardiomyopathy be suspected, and what is the differential diagnosis? What…
Apr 02, 2025
AbstractAmyloid light-chain (AL) amyloidosis is characterized by the deposition of amyloid fibrils in various organs, although gallbladder involvement is rare. We…
Apr 02, 2025
AbstractBackgroundLeft atrial appendage occlusion (LAAO) is a valuable alternative therapy to anticoagulants for stroke prevention, and a representative study has…
Apr 02, 2025
Loneliness is a neuropsychiatric symptom that has been associated with cognitive impairment and dementia. We aimed to investigate whether depressive symptomatology…
Apr 01, 2025
ObjectiveIdentification of clinically meaningful subphenotypes of disease progression can enhance the understanding of disease heterogeneity and underlying…
Apr 01, 2025
PurposeAccording to a WHO statement, it has been asserted that there is no safe level of alcohol consumption regarding human health. Nevertheless, the relationship…
Mar 31, 2025
AbstractThe progressive number of old adults with cognitive impairment worldwide and the lack of effective pharmacologic therapies require the development of non-…
Mar 31, 2025
Key PointsQuestionWhat is the safety, tolerability, and efficacy of N-acetylcysteine (NAC) for patients with hereditary cystatin C amyloid angiopathy (HCCAA)?…
Mar 26, 2025
AbstractThe amyloid hypothesis has been a leading narrative concerning the pathophysiological foundation of Alzheimer’s and Parkinson’s disease. At the two ends of…
Mar 24, 2025
AbstractYears of experience watching our patients progressively decline and die from complications of Alzheimer's disease (AD) has strongly motivated us to provide…